bioRxiv / medRxiv
open access
Conscious Sedation with Dexmedetomidine or Midazolam during Endovascular Thrombectomy in Acute Ischemic Stroke: Protocol of the Multicenter PEACE Randomized Trial
BackgroundDexmedetomidine (DEX) and midazolam (MDZ) are commonly used agents for conscious sedation in patients with acute ischemic stroke (AIS) treated with endovascular thrombectomy (EVT). While DEX offers superior sedation quality and potential neuroprotective effects, it is also associated with
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone Dexborneol#864043
- ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo#1381904
- Effects of Post-Operative Sedation for Endovascular Thrombectomy#857215
- Comparative effectiveness of Tenecteplase and Alteplase for ischemic stroke : real-world data from a stroke center#1390957
- Intranasal Sedation With Dexmedetomidine#879921
Record · ID 1495268
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive